Xilio Therapeutics Inc Sustainability Reports
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops tumor-selective immuno-oncology therapies. Its proprietary platform masks molecules to activate preferentially within the tumor microenvironment, minimizing systemic toxicity for cancer patients.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
3 reports from 2022 to 2024